Search results for "Imidazole"
showing 10 items of 611 documents
CCDC 1000179: Experimental Crystal Structure Determination
2015
Related Article: Zsolt Szakonyi, István Zupkó, Reijo Sillanpää and Ferenc Fülöp|2014|Molecules|19|15918|doi:10.3390/molecules191015918
CCDC 722404: Experimental Crystal Structure Determination
2010
Related Article: M.Leboschka, M.Sieger, B.Sarkar, J.Heck, M.Niemeyer, D.Bubrin, F.Lissner, T.Schleid, S.Zalis, Cheng-Yong Su, W.Kaim|2009|Z.Anorg.Allg.Chem.|635|2177|doi:10.1002/zaac.200900265
CCDC 1439889: Experimental Crystal Structure Determination
2016
Related Article: Emilio Escrivà, José-Vicente Folgado, Guillermo Mínguez Espallargas, Lucia Soto, Amparo Sancho, Lourdes Perelló, Rosa Ortíz|2016|Polyhedron|112|137|doi:10.1016/j.poly.2016.03.041
CCDC 651165: Experimental Crystal Structure Determination
2008
Related Article: J.Martinez-Lillo, D.Armentano, G.De Munno, F.Lloret, M.Julve, J.Faus|2008|Dalton Trans.||40|doi:10.1039/b714563b
2,4,5-Triaryl imidazole probes for the selective chromo-fluorogenic detection of Cu(II). Prospective use of the Cu(II) complexes for the optical reco…
2019
The sensing behaviour toward metal cations and biothiols of two 2,4,5-triarylimidazole probes (3a and 3b) is tested in acetonitrile and in acetonitrile-water. In acetonitrile the two probes present charge-transfer absorption bands in the 320-350 nm interval. Among all cations tested only Cu(11) is able to induce bathochromic shifts of the absorption band in the two probes, which is reflected in marked colour changes. Colour modulations are ascribed to the formation of 1:1 Cu(II)-probe complexes in which the cation interacts with the imidazole acceptor heterocycle. Besides, the two probes present intense emission bands (at 404 and 437 nm for 3a and 3b respectively) in acetonitrile that are q…
Bis(2-methylbenzimidazole-κN1)copper(I) dichlorocuprate(I)
2004
By using alternating-current electrochemical synthesis, crystals of the copper(I) ionic compound composed of [Cu(C8H8N2)2]+ and [CuCl2]− ions have been obtained and structurally investigated. Both crystallographically independent Cu atoms lie on centres of inversion and exhibit the less-common coordination number 2. A linear arrangement of the metal atoms includes two N atoms of the different organic moieties in the [Cu(2-methylbenzimidazole)2]+ cation and two Cl atoms in the case of the inorganic anion.
Magneto-structural correlations in a family of ReIVCuII chains based on the hexachlororhenate(IV) metalloligand
2017
Six novel one-dimensional chloro-bridged ReIVCuII complexes of formula {[Cu(L)4][ReCl6]}n, where L = imidazole (Imi, 1), 1-methylimidazole (Meim, 2), 1-vinylimidazole (Vim, 3), 1-butylimidazole (Buim, 4), 1-vinyl-1,2,4-triazole (Vtri, 5) and N,N’-dimethylformamide (DMF, 6) are characterised structurally, magnetically and theoretically. The structures exhibit significant differences in Cu–Cl bond lengths and Re–Cl–Cu bridging angles, resulting in large differences in the nature and magnitude of magnetic exchange interactions between the ReIV and CuII ions. Theoretical calculations reveal the coupling to be primarily ferromagnetic, increasing in magnitude as the bridging angle becomes smaller…
Metal Complexes of Two Specific Regions of ZnuA, a Periplasmic Zinc(II) Transporter from Escherichia coli
2020
The crystal structure of ZnZnuA from Escherichia coli reveals two metal binding sites. (i) The primary binding site, His143, is located close the His-rich loop (residues 116-138) and plays a significant role in Zn(II) acquisition. (ii) The secondary binding site involves His224. In this work, we focus on understanding the interactions of two metal ions, Zn(II) and Cu(II), with two regions of ZnuA, which are possible anchoring sites for Zn(II): Ac-115MKSIHGDDDDHDHAEKSDEDHHHGDFNMHLW145-NH2 (primary metal binding site) and Ac-223GHFTVNPEIQPGAQRLHE240-NH2 (secondary metal binding site). The histidine-rich loop (residues 116-138) has a role in the capture of zinc(II), which is then further deliv…
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced…
2019
Abstract Purpose: IDO1 induces immune suppression in T cells through l-tryptophan (Trp) depletion and kynurenine (Kyn) accumulation in the local tumor microenvironment, suppressing effector T cells and hyperactivating regulatory T cells (Treg). Navoximod is an investigational small-molecule inhibitor of IDO1. This phase I study evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics of navoximod in combination with atezolizumab, a PD-L1 inhibitor, in patients with advanced cancer. Patients and Methods: The study consisted of a 3+3 dose-escalation stage (n = 66) and a tumor-specific expansion stage (n = 92). Navoximod was given orally every 12 hours continuously for 21 consecu…
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
2016
// Daniele Fanale 1, * , Valeria Amodeo 1, * , Viviana Bazan 1, * , Lavinia Insalaco 1 , Lorena Incorvaia 1 , Nadia Barraco 1 , Marta Castiglia 1 , Sergio Rizzo 1 , Daniele Santini 2 , Antonio Giordano 3 , Sergio Castorina 4, 5, # , Antonio Russo 1, # 1 Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy 2 University Campus Bio-Medico, Department of Medical Oncology, Rome, Italy 3 Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA 4 Fondazione Mediterranea “G.B. Morgagni”, Catania, Italy 5 Department of Biomedic…